Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

APHRANEL Global Launch Meeting, in Shanghai China

APHRANEL Global Launch Meeting: Code Breaker, World Maker SHANGHAI, April 9, 2025 /PRNewswire/ -- On May 8, 2025——The APHRANEL Global Launch Meeting will...

viaim’s NoteKit AI Voice Recorder Poised to Transform North American Classrooms, Boosting Educator Efficiency

NEW YORK, April 9, 2025 /PRNewswire/ -- viaim, an AI hardware company specializing in smart office solutions, is preparing for the official North American launch...

EQT, Hg and TA-owned IFS valued at EUR 15 billion in minority stake sale, following investment from Hg, ADIA and CPP Investments

Hg increases its stake in enterprise software provider IFS and becomes co-control shareholder alongside EQT, while existing minority shareholder TA Associates...

IFS Attracts EUR 15 billion Valuation as Demand for Industrial AI Soars

Hg increases its stake in enterprise software provider IFS and becomes co-control shareholder alongside EQT, while existing minority shareholder TA...